Bionano Genomics News

Bionano Stock Climbs 7% in Wake of Q1 Report, Software Upgrades

Seeking Alpha31minutes ago

Bionano Genomics, Inc. (NASDAQ:BNGO) Q1 2024 Earnings Call Transcript

Yahoo Finance00:08

BioNano Genomics (BNGO) Gets a Buy From Scotiabank

TipRanksMay 9 19:25

Q1 2024 Bionano Genomics Inc Earnings Call

Yahoo FinanceMay 9 18:03

Bionano Genomics Inc (BNGO) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth ...

Yahoo FinanceMay 9 15:44

Bionano Announces Series of Major Advancements to Its Suite of Computational Tools for Comprehensive Cancer Analysis

SAN DIEGO, May 09, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced significant upgrades to its suite of computational tools for comprehensive cancer analysis. These ad

BioNano GenomicsMay 9 12:00

Bionano Genomics, Inc. (BNGO) Q1 2024 Earnings Call Transcript

Bionano Genomics, Inc. (BNGO) Q1 2024 Earnings Call Transcript

Earnings Call TranscriptsMay 9 07:12

Bionano Genomics (BNGO) Q1 2024 Earnings Call Transcript

Yahoo FinanceMay 9 06:30

Bionano Reaffirms FY24 Revenue Guidance $37M-$41M

Bionano Reaffirms FY24 Revenue Guidance $37M-$41M

BenzingaMay 9 05:39

Bionano Genomics up 7% on Narrowed Quarterly Loss, Revenue Beat

Seeking AlphaMay 9 04:54

Bionano Genomics Q1 2024 GAAP EPS $(0.60) Beats $(0.65) Estimate, Sales $8.769M Beat $8.492M Estimate

Bionano Genomics (NASDAQ:BNGO) reported quarterly losses of $(0.60) per share which beat the analyst consensus estimate of $(0.65) by 7.69 percent. This is a 51.22 percent increase over losses of $(1.

BenzingaMay 9 04:37

10-Q: Quarterly report

Futu NewsMay 9 04:16 · Announcements

Bionano Genomics 1Q Rev $8.8M >BNGO

Bionano Genomics 1Q Rev $8.8M >BNGO

Dow JonesMay 9 04:09

Bionano Genomics Sees 2Q Rev $7.8M-$8.2M >BNGO

Bionano Genomics Sees 2Q Rev $7.8M-$8.2M >BNGO

Dow JonesMay 9 04:09

Press Release: Bionano Reports First Quarter 2024 Results and Highlights Recent Business Progress

Bionano Reports First Quarter 2024 Results and Highlights Recent Business Progress -- Q1 2024 revenue was $8.8 million, which represents an 18% increase over Q1 2023 -- Total installed ba

Dow JonesMay 9 04:01

Bionano to Report First Quarter 2024 Financial Results and Host a Conference Call and Webcast on May 8, 2024

SAN DIEGO, May 01, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Wednesday, May 8, 2024, at 4:30 p.m. Eastern

BioNano GenomicsMay 1 12:00

Bionano to Present at the RBC Capital Markets 2024 Global Healthcare Conference

SAN DIEGO, April 30, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano's president and chief executive officer, will present at the RBC C

BioNano GenomicsApr 30 12:00

Bionano Announces Publication Showing OGM's High Resolution Structural Variation Detection In Cancer Validated By Cas9-Directed Nanopore Sequencing

Bionano Genomics, Inc. (NASDAQ:BNGO), today announced the results of an implementation study conducted by researchers at University Medical Center Groningen that compared optical genome mapping (OGM)

BenzingaApr 24 20:14

Bionano Genomics, Hangzhou Diagens Biotechnology to Commercialize Cytogenetic Workflow for Reproductive Health

Bionano Genomics (BNGO) said Wednesday it has entered into an original equipment manufacturing partnership with Hangzhou Diagens Biotechnology to commercialize cytogenetic workflow to support reproduc

MT NewswiresApr 18 00:22

Bionano Enters OEM Partnership With Diagens To Commercialize A Clinical Cytogenetic Analysis That Combines OGM And Artificial Intelligence

Bionano Enters OEM Partnership With Diagens To Commercialize A Clinical Cytogenetic Analysis That Combines OGM And Artificial Intelligence

BenzingaApr 17 20:03